Reply to Randone Et Al - Rescue with Obinutuzumab and Daratumumab As Combined B-cell/Plasma Cell Targeting Approach in Severe Post-Transplant FSGS Recurrence
American Journal of Transplantation（2024）
关键词
kidney transplant,focal segmental glomerulosclerosis,disease recurrence,daratumumab,anti-CD20 antibody,anti-CD38 antibody,nephrotic syndrome
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要